Early-stage breast cancer (BC) patients: Factors associated with aromatase inhibitor-induced musculoskeletal symptoms.

Presenter

null

Simran Arora Elder, MD, BA

University of Maryland Greenebaum Comprehensive Cancer Center

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 38: 2020 (suppl; abstr 525)

DOI

10.1200/JCO.2020.38.15_suppl.525

Abstract #

525

Poster Bd #

17

Abstract Disclosures

Similar Videos & Slides

Videos & Slides

2018 ASCO Annual Meeting

Panel Question and Answer

Panel Question and Answer

Speaker: Panel Discussion

Videos & Slides

2024 ASCO Annual Meeting

Patterns of depressive symptoms among survivors of early-stage breast cancer (BC).

Patterns of depressive symptoms among survivors of early-stage breast cancer (BC).

Speaker: Antonio Di Meglio, MD, PhD

Videos & Slides

2024 ASCO Annual Meeting

Utilizing Biomarkers to Refine Prognostication and Treatment Selection in Early-Stage Breast Cancer

Utilizing Biomarkers to Refine Prognostication and Treatment Selection in Early-Stage Breast Cancer

Speaker: Francois Clement Bidard, MD, PhD

Videos & Slides

2024 ASCO Annual Meeting

The impact of adjuvant endocrine therapy (AET) omission in ER-low (1-10%) early-stage breast cancer.

The impact of adjuvant endocrine therapy (AET) omission in ER-low (1-10%) early-stage breast cancer.

Speaker: Grace Mei Yee Choong, MD